Skip to main content
. 2014 Feb 26;9(2):e89803. doi: 10.1371/journal.pone.0089803

Table 1. In vitro neutralization activity of antibodies against a panel of HA from influenza A viruses.

Antibody HA from Strains* GC 0346 GC 0352 GC 0587 GC 0757 GC 1245 GC 1289 GC 1517 GC 1747 GC 1761
A/Brisbane/59/2007(H1N1) ++ ++ ++ +
A/California/04/2009(H1N1) ++ + ++ ++ ++ ++
A/Brevig Mission/1/1918(H1N1) ++ ++ ++
A/California/07/2009(H1N1) ++ ++ ++ ++ ++ ++
A/Japan/305/1957(H2N2) ++
A/Brisbane/10/2007(H3N2)
A/Anhui/1/2005(H5N1)
A/Indonesia/5/2005(H5N1)
A/Viet Nam/1194/2004(H5N1)
A/Viet Nam/1203/2004(H5N1)
A/bar-headed goose/Qinghai/14/2008 (H5N1) ++
A/turkey/Turkey/1/2005(H5N1)
A/Netherlands/219/03(H7N7)
2009 pandemic vaccine ++ ++ ++ ++ ++ ++ ++ + ++

+represents a positive neutralization activity of each antibody determined by ELISA and –represents a negative neutralizing activity.

*A/California/04/2009(H1N1), A/Brisbane/59/2007(H1N1), A/California/04/2009(H1N1), A/Brevig Mission/1/1918(H1N1), A/California/07/2009(H1N1), A/Japan/305/1957(H2N2), A/Brisbane/10/2007(H3N2), A/Anhui/1/2005(H5N1), A/bar-headed goose/Qinghai/14/2008(H5N1), A/Indonesia/5/2005(H5N1), A/turkey/Turkey/1/2005(H5N1), A/Viet Nam/1194/2004(H5N1), A/Viet Nam/1203/2004(H5N1), A/Netherlands/219/03(H7N7).

HHS Vulnerability Disclosure